Diet Blogs

Protein has become the nutrient everyone seems to want more of. It is added to cereal, coffee, snack bars, and products that once made no claim to be muscle food.

GLP-1 drugs have changed what is possible in obesity treatment. Semaglutide and related medicines can produce weight loss that once required bariatric surgery. But the number on the scale does not tell the whole story. When body weight falls, some of the loss comes from fat and some comes from lean tissue - a category that includes skeletal muscle, organs, connective tissue, water, and glycogen.

Sorghum is not the first grain most people think of when they hear about brain health. Oats, blueberries, olive oil, and leafy greens usually get more attention. But sorghum, especially darker pigmented varieties, is starting to interest researchers because it contains a rich mix of plant polyphenols—compounds that can influence oxidative stress, inflammation, metabolism, and cell signaling.

Magnesium has always had a quiet, behind-the-scenes job in the body. It helps nerves communicate, muscles contract, blood pressure stay regulated, and hundreds of enzymes do their work [1]. So it is not surprising that supplement makers, researchers, and consumers have wondered whether magnesium might also matter for the brain. A new randomized clinical trial adds an interesting piece to that puzzle: in adults with poor sleep, six weeks of magnesium L-threonate, sold under the ingredient name Magtein, was linked with better scores on some cognitive tests and an estimated 7.5-year improvement in cognitive age compared with placebo [2].

Survodutide is not approved as a consumer treatment for fatty liver disease. That is the first bucket to keep the facts in. The second bucket is more interesting: a new phase 3 trial gives the drug a real reason to be watched closely. Phase 3 means the treatment has moved past small early studies and is being tested in a larger, more serious way before regulators decide what to do with it. The SYNCHRONIZE-MASLD study tested once-weekly survodutide, an injectable drug that turns on two body signaling systems: the glucagon receptor and the GLP-1 receptor. GLP-1 is the family of signals made famous by newer weight-loss and diabetes drugs. Glucagon is a different signal involved in how the body handles stored fuel. Put them together and you get a drug designed to push on weight, blood sugar, fat metabolism, and possibly the liver itself [1].

Nattokinase sounds like a lab-made drug, but it starts in a very ordinary place: natto, the sticky fermented soybean food popular in Japan. During fermentation, Bacillus subtilis var. natto produces an enzyme that can break down fibrin, one of the protein threads that helps blood clots hold together. That basic fact explains why nattokinase has attracted so much attention for heart and blood-vessel health. It also explains why the claims around it need careful handling. An enzyme that nudges clotting biology is not the same thing as a proven replacement for aspirin, statins, blood-pressure medicine, or anticoagulants

Edited and approved by Stephen C. Rose, PhD, MS

The metabolic loop begins with mTORC1, a nutrient-sensing growth switch, being pushed toward the on position. Insulin resistance builds; the familiar markers of metabolic syndrome begin to appear. But a long-running metabolic problem does not stay...

Vitamin C has been around the wellness world so long that it almost feels boring. People associate it with oranges, immune support, and avoiding scurvy. So it was surprising when a 2026 Cell Metabolism study put vitamin C into a much more modern aging-science story. The researchers proposed a new aging pathway they called "ferro-aging," centered on iron buildup, lipid damage, and an enzyme called ACSL4. Even more attention-grabbing, they reported that long-term vitamin C treatment in aged monkeys reduced several ferro-aging signatures, improved some neurological and metabolic measures, and shifted multi-omic aging clocks in a younger direction

The switch is mTORC1 on one side, AMPK on the other, and a molecular logic that was built for a world of alternating feast and famine. In that world, the switch flipped regularly. Neither side stayed dominant for long. The modern environment broke that rhythm — and when the switch got stuck, something else happened that is more consequential than a switch simply being in the wrong position. A feedback loop formed. The stuck switch began generating the conditions that kept it stuck. And once that loop is running, the familiar tools — eating less, trying harder, starting over — can make it worse rather than better.

Part One: The Switch You have done everything right. You cut the calories, gave up the bread, the wine, the desserts that used to feel like a reasonable reward for getting through the week. For a while it worked. Then it stopped